Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Insulin isophane biphasic human 15/85 100units/ml injection 3ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin lispro biphasic (recombinant human insulin analogue) 25/75 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin aspart (recombinant human insulin analogue) 100units/ml inject |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin lispro (recombinant human insulin analogue) 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 40/60 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin aspart 100units/mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
bifasisk insulin aspart 30/70 100 enheder/ml injektionsvæske, cylinderampul a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
bifasisk insulin aspart 30/70 100 enheder/ml injektionsvæske i fyldt pen a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Human isophane insulin 100units/mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin lispro |
Is a |
True |
Human insulin |
Inferred relationship |
Some |
|
Insulin human 100units/mL buffered regular solution injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Product containing insulin detemir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Product containing insulin glargine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Product containing human isophane insulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
humant insulin zink suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
insulin detemir 100 IE/ml injektionsvæske, opløsning, cylinderampul a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
insulin detemir 100 IE/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
insulin glargin (rekombinant humant insulinanalog) 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
insulin glargin (rekombinant human insulinanalog) 100 enheder/ml injektionsvæske, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
insulin glargin (rekombinant humant insulinanalog) 100 enheder/ml injektionsvæske, 3 ml fyldt injektionsudstyr til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
humant insulin 100 enheder/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Human insulin soluble |
Is a |
True |
Human insulin |
Inferred relationship |
Some |
|
Human insulin zinc suspension crystalline (substance) |
Is a |
True |
Human insulin |
Inferred relationship |
Some |
|
human insulin-zink-suspension, blandet |
Is a |
False |
Human insulin |
Inferred relationship |
Some |
|
Human isophane insulin (substance) |
Is a |
True |
Human insulin |
Inferred relationship |
Some |
|
Lente human insulin (substance) |
Is a |
True |
Human insulin |
Inferred relationship |
Some |
|
Product containing human insulin zinc suspension crystalline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
humant insulin 1 mg enkeltdosis, blister, tørt inhalationpulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
humant insulin 3 mg enkeltdosis, blister, tørt inhalationpulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
insulin detemir 100 IE/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin detemir (substance) |
Is a |
True |
Human insulin |
Inferred relationship |
Some |
|
Insulin glulisine (substance) |
Is a |
True |
Human insulin |
Inferred relationship |
Some |
|
Insulin glargine (substance) |
Is a |
True |
Human insulin |
Inferred relationship |
Some |
|
rekombinant humant insulinanalogpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Product containing human insulin in respiratory dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Allergy to human insulin |
Causative agent |
True |
Human insulin |
Inferred relationship |
Some |
1 |
Biphasic isophane insulin human |
Is a |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin aspart protamine (substance) |
Is a |
True |
Human insulin |
Inferred relationship |
Some |
|
Product containing precisely human insulin (as human insulin soluble) 1000 unit/10 milliliter conventional release solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Human insulin |
Inferred relationship |
Some |
1 |
Product containing precisely human insulin (as insulin glargine) 1000 unit/10 milliliter conventional release solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Human insulin |
Inferred relationship |
Some |
1 |
Product containing precisely human insulin (as human insulin soluble) 150 unit/1.5 milliliter conventional release solution for injection cartridge |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Human insulin |
Inferred relationship |
Some |
1 |
Product containing precisely human insulin (as human insulin soluble) 500 unit/5 milliliter conventional release solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Human insulin |
Inferred relationship |
Some |
1 |
Product containing precisely human insulin (as human insulin zinc suspension crystalline) 1000 unit/10 milliliter conventional release suspension for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Human insulin |
Inferred relationship |
Some |
1 |
Product containing precisely human insulin (as human insulin zinc suspension mixed) 1000 unit/10 milliliter conventional release suspension for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Human insulin |
Inferred relationship |
Some |
1 |
Product containing precisely human insulin (as human isophane insulin) 300 unit/3 milliliter conventional release suspension for injection cartridge |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Human insulin |
Inferred relationship |
Some |
1 |
Product containing precisely human insulin (as human insulin soluble) 300 unit/3 milliliter conventional release solution for injection cartridge |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Human insulin |
Inferred relationship |
Some |
1 |
Product containing precisely human insulin (as insulin glargine) 300 unit/3 milliliter conventional release solution for injection cartridge |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Human insulin |
Inferred relationship |
Some |
1 |
Product containing precisely human insulin (as insulin glargine) 300 unit/3 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Human insulin |
Inferred relationship |
Some |
1 |
Product containing precisely human insulin (as human insulin soluble) 300 unit/3 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Human insulin |
Inferred relationship |
Some |
1 |
Product containing precisely human insulin (as human isophane insulin) 300 unit/3 milliliter conventional release suspension for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Human insulin |
Inferred relationship |
Some |
1 |
Product containing human insulin in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
1 |
Product containing only human insulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
1 |
Product containing only human insulin in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
1 |
Product containing precisely human insulin (as human insulin zinc suspension mixed) 100 unit/1 milliliter conventional release suspension for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Human insulin |
Inferred relationship |
Some |
1 |
Product containing precisely human insulin (as human insulin zinc suspension crystalline) 100 unit/1 milliliter conventional release suspension for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Human insulin |
Inferred relationship |
Some |
1 |
Product containing precisely human insulin (as human isophane insulin) 100 unit/1 milliliter conventional release suspension for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Human insulin |
Inferred relationship |
Some |
1 |
Product containing precisely human insulin (as insulin glargine) 100 unit/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Human insulin |
Inferred relationship |
Some |
1 |
Product containing precisely human insulin (as human insulin soluble) 100 unit/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Human insulin |
Inferred relationship |
Some |
1 |
Insulin lispro protamine (substance) |
Is a |
True |
Human insulin |
Inferred relationship |
Some |
|
Adverse reaction caused by human insulin (disorder) |
Causative agent |
True |
Human insulin |
Inferred relationship |
Some |
1 |